Parlange Bernardo 4

What Happened Bernardo Parlange, Chief Commercial Officer of Proto Labs, received equity awards on May 20, 2026: 2,109 restricted stock units (RSUs) and 3,789 RSUs reported as a derivative award. Each grant shows an acquisition price of $0.00 on the Form 4 (awarded shares, not purchased), for a total of 5,898 RSUs granted. These are time‑based awards (not open‑market buys or sales).

Key Details

• Transaction date: May 20, 2026; Form 4 filed May 22, 2026 (timely).
• Reported price: $0.00 (award grant). Reported acquisition type: A = Award/Grant; one award listed as derivative.
• Total shares granted: 2,109 + 3,789 = 5,898 RSUs.
• Shares owned after transaction: not specified in the provided filing summary.
• Footnotes: Both awards vest 25% on May 20, 2027 and 25% on each May 20 thereafter until fully vested.
• No 10b5‑1 plan, tax‑withholding, or immediate sale reported in this filing.

Context These are standard time‑vesting RSU grants that do not represent a market purchase or sale and typically serve as long‑term compensation. The derivative designation means the second award is an equity award (RSUs) rather than a direct share purchase. Awards vest over multiple years, so they do not increase immediately tradable shares.